Mesías-Gazmuri, Jocelyn
Folch, Cinta
Palacio-Vieira, Jorge
Bruguera, Andreu
Egea-Cortés, Laia
Forero, Carlos G.
Hernández, Juan
Miró, José M.
Navarro, Jordi
Riera, Melchor
Peraire, Joaquim
Alonso-García, Lucía
Díaz, Yesika
Casabona, Jordi
Reyes-Urueña, Juliana
Article History
Received: 19 October 2022
Accepted: 24 April 2023
First Online: 10 May 2023
Change Date: 30 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12955-023-02139-5
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Ethics approval for the study was obtained from the Ethics Committee of the Germans Trias i Pujol Hospital (Nº PI-19–172), and permission to conduct the study in the all the health facilities was granted by Ethics Committee from each hospital.
: Not applicable.
: J. Peraire has received conference grants or speaker fees from ViiV Healthcare and Gilead. JN has received fees for educational activities and/or consultancies and/or financial support for attending conferences from Abbvie, Gilead Science, Janssen-Cilag, Merck Sharp & Dohme and ViiV Healthcare out of the submitted work. JMM has received consulting honoraria and/or research grants from Angelini, Contrafect, Genentech, Gilead Sciences, Jansen, Lysovant, Medtronic, MSD, Pfizer, and ViiV Healthcare. JMG received a research grant from ANID/SUBDIRECCIÓN CAPITAL HUMANO/ DOCTORADO BECASCHILE 2017/ FOLIO 72180457 and a predoctoral contract for Training in Health Research PFIS. JMM received a personal 80:20 research grant from Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017–22.